Fate Therapeutics, Inc.

Historical 13F Holders

Symbol
FATE
CUSIP
31189P102
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 132 93.9 M $74.2 M
2024 Q4 161 102 M $166 M
2024 Q3 168 116 M $408 M
2024 Q2 189 127 M $416 M
2024 Q1 178 131 M $961 M
2023 Q4 164 99.4 M $372 M
2023 Q3 174 95.7 M $203 M
2023 Q2 197 109 M $520 M
2023 Q1 190 113 M $642 M
2022 Q4 241 112 M $1.13 B
2022 Q3 251 109 M $2.45 B
2022 Q2 246 110 M $2.70 B
2022 Q1 269 101 M $3.93 B
2021 Q4 269 97.2 M $5.68 B
2021 Q3 284 95.9 M $5.68 B
2021 Q2 290 94.5 M $8.20 B
2021 Q1 278 94.0 M $7.75 B
2020 Q4 275 87.7 M $7.98 B
2020 Q3 228 87.8 M $3.51 B
2020 Q2 219 86.0 M $2.95 B
2020 Q1 174 80.1 M $1.78 B
2019 Q4 162 73.1 M $1.43 B
2019 Q3 159 77.5 M $1.22 B
2019 Q2 148 63.2 M $1.28 B
2019 Q1 131 60.8 M $1.07 B
2018 Q4 131 60.1 M $771 M
2018 Q3 126 55.2 M $898 M
2018 Q2 110 43.1 M $489 M
2018 Q1 93 39.5 M $385 M
2017 Q4 79 35.3 M $216 M
2017 Q3 74 25.4 M $101 M
2017 Q2 60 26.6 M $86.2 M
2017 Q1 54 25.6 M $117 M
2016 Q4 38 23.7 M $59.3 M
2016 Q3 40 19.5 M $60.8 M
2016 Q2 40 14.1 M $24.0 M
2016 Q1 46 15.8 M $28.4 M
2015 Q4 54 18.6 M $62.7 M
2015 Q3 44 18.3 M $97.8 M
2015 Q2 39 18.0 M $117 M
2015 Q1 25 10.6 M $51.9 M
2014 Q4 24 10.3 M $51.8 M
2014 Q3 22 10.3 M $52.6 M
2014 Q2 23 9.89 M $62.7 M
2014 Q1 21 9.56 M $92.8 M